XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating Activities    
Net income including the noncontrolling interests in subsidiaries $ 51,027 $ 48,959
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities    
Amortization of deferred sales commissions 2,608 2,904
Depreciation and other amortization 2,584 2,351
Share-based compensation expense 6,672 7,237
(Gain) loss on disposal of assets (1,514) 1,174
Provision for deferred income taxes 5,780 9,270
Adoption of new accounting pronouncement 0 (2,653)
Net sales (purchases) of trading securities 2,516 (2,831)
Deferred sales commissions paid (1,324) (3,012)
Contingent deferred sales charges received 612 578
Other changes in assets and liabilities:    
Decrease (increase) in receivables, net 98 (7,454)
Increase in prepaid expenses and other assets (590) (1,750)
Decrease in accounts payable and accrued expenses (57,632) (41,722)
Increase in other liabilities 22,187 13,190
Net cash provided by operating activities 33,024 26,241
Investing Activities    
Purchases of securities available for sale (651) (823)
Cash paid for business acquisitions (4,352) 0
Proceeds from redemptions of securities available for sale 12,450 50
Cash paid for property and equipment (2,133) (3,257)
Net cash provided (used) by investing activities 5,314 (4,030)
Financing Activities    
Dividends paid (25,467) (25,990)
Purchases of treasury stock (14,871) (13,728)
Distributions to noncontrolling interest in subsidiaries (4,443) (6,345)
Contributions from noncontrolling interest in subsidiaries 2,818 5,431
Cash paid for business acquisitions (210) (70)
Payments on debt (6,375) (6,375)
Net cash used by financing activities (48,548) (47,077)
Net decrease in cash and cash equivalents (10,210) (24,866)
Cash and cash equivalents, beginning of period 104,839 172,628
Cash and cash equivalents, end of period $ 94,629 $ 147,762